These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9695293)

  • 1. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
    Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C
    Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N; Sugimura T; Akagi T; Yamakawa R; Hashino K; Eto G; Iemura M; Ishii M; Kato H
    Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
    JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
    Liu MY; Liu HM; Wu CH; Chang CH; Huang GJ; Chen CA; Chiu SN; Lu CW; Lin MT; Chang LY; Wang JK; Wu MH
    BMC Pediatr; 2017 Jun; 17(1):139. PubMed ID: 28587647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous gamma-globulin for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of vascular leakage in acute Kawasaki disease.
    Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y
    Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New hope for children with Kawasaki disease.
    Lux KM
    J Pediatr Nurs; 1991 Jun; 6(3):159-65. PubMed ID: 1710660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S; Matsubara T; Umezawa Y; Motohashi T; Ino T; Yabuta K
    Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm.
    Nomura Y; Masuda K; Yoshinaga M; Sameshima K; Miyata K
    Pediatr Int; 2002 Aug; 44(4):353-7. PubMed ID: 12139556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant coronary aneurysms due to Kawasaki disease: a case-control study.
    Nakamura Y; Yashiro M; Oki I; Tanihara S; Ojima T; Yanagawa H
    Pediatr Int; 2002 Jun; 44(3):254-8. PubMed ID: 11982891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
    Koyanagi H; Nakamura Y; Yanagawa H
    Acta Paediatr; 1998 Jan; 87(1):32-6. PubMed ID: 9510444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease in infants less than one year of age.
    Rosenfeld EA; Corydon KE; Shulman ST
    J Pediatr; 1995 Apr; 126(4):524-9. PubMed ID: 7699529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease.
    Morikawa Y; Ohashi Y; Harada K; Asai T; Okawa S; Nagashima M; Katoh T; Baba K; Furusho K; Okuni M; Osano M
    Pediatr Int; 2000 Oct; 42(5):464-9. PubMed ID: 11059532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease.
    Han RK; Silverman ED; Newman A; McCrindle BW
    Arch Pediatr Adolesc Med; 2000 Jul; 154(7):694-9. PubMed ID: 10891021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
    Miura M; Ohki H; Tsuchihashi T; Yamagishi H; Katada Y; Yamada K; Yamashita Y; Sugaya A; Komiyama O; Shiro H
    Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder.
    Nomura Y; Arata M; Masuda K; Koriyama C; Suruki N; Ueno K; Yoshikawa H; Eguchi T; Kawano Y
    Pediatr Int; 2012 Feb; 54(1):14-8. PubMed ID: 22115193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR; Hwang KP; Tu JG; Dai ZK; Huang TY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.